FDA Approves First Prescription App for Depression
The US Food and Drug Administration has approved the first-ever prescription app for major depressive disorder.
Stay updated with breaking news from John Torous. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Food and Drug Administration has approved the first-ever prescription app for major depressive disorder.
Demand for mental health apps has soared in recent years but many fail to meet the quality threshold for issues such as clinical effectiveness, data privacy and security
The Rejoyn therapy app was approved by the FDA as add-on treatment for adults with depression who are already taking an antidepressant.
The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.
Washington, Apr 4 (Prensa Latina) Rejoyn, the first digital prescription treatment against major depressive disorder, received the green light from the United States Food and Drug Administration; however, some experts remain skeptical about this initiative.